IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Thursday reported a loss of $23.9 million in its second quarter.
The Irvine, California-based company said it had a loss of 28 cents per share. Losses, adjusted for non-recurring costs, came to 18 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The medical device company posted revenue of $44.7 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $44.4 million.
Endologix expects a full-year loss of $1.12 to $1.04 per share, with revenue in the range of $145 million to $155 million.
In the final minutes of trading on Thursday, the company's shares hit $4.72. A year ago, they were trading at $4.29.
No comments:
Post a Comment